News | March 21, 2026
Bristol Myers Squibb scores major win with new Opdivo nods for Hodgkin Lymphoma in US, EU
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility features 2,176 high-performance GPUs across the US and Europe
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
Subscribe To Our Newsletter & Stay Updated
